Increased Platelet to Lymphocyte Ratio is Related to Slow Coronary Flow

Mehmet Kadri Akboga1, Ugur Canpolat2, Kevser Gulcihan Balci2

  • 1Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey mkakboga@yahoo.com.

Angiology
|March 1, 2015
PubMed

Insights

The platelet to lymphocyte ratio (PLR) is linked to slow coronary flow (SCF), a condition affecting heart arteries. Higher PLR levels independently predict the presence of SCF and correlate with inflammation markers.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Inflammation and platelets are implicated in slow coronary flow (SCF).
  • Platelet to lymphocyte ratio (PLR) is an emerging inflammatory marker associated with cardiovascular events.

Purpose of the Study:

  • To investigate the association between PLR and SCF.
  • To determine if PLR is an independent predictor of SCF.

Main Methods:

  • Retrospective study including 221 patients with SCF and 293 controls.
  • SCF diagnosed using thrombolysis in myocardial infarction frame counts (TFC).
  • Analyzed PLR and C-reactive protein (CRP) levels.

Main Results:

  • PLR and CRP levels were significantly higher in the SCF group.
  • PLR showed a significant positive correlation with TFC in all coronary arteries and with CRP.
  • PLR was independently associated with the presence of SCF (OR: 1.014, P < .001).

Conclusions:

  • Elevated PLR is significantly and independently associated with the presence of SCF.
  • PLR correlates positively with CRP, indicating a link to systemic inflammation.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
646
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
592